Seidel, F.; Kleemann, R.; van Duyvenvoorde, W.; van Trigt, N.; Keijzer, N.; van der Kooij, S.; van Kooten, C.; Verschuren, L.; Menke, A.; Kiliaan, A.J.;
et al. Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. Int. J. Mol. Sci. 2022, 23, 10736.
https://doi.org/10.3390/ijms231810736
AMA Style
Seidel F, Kleemann R, van Duyvenvoorde W, van Trigt N, Keijzer N, van der Kooij S, van Kooten C, Verschuren L, Menke A, Kiliaan AJ,
et al. Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences. 2022; 23(18):10736.
https://doi.org/10.3390/ijms231810736
Chicago/Turabian Style
Seidel, Florine, Robert Kleemann, Wim van Duyvenvoorde, Nikki van Trigt, Nanda Keijzer, Sandra van der Kooij, Cees van Kooten, Lars Verschuren, Aswin Menke, Amanda J. Kiliaan,
and et al. 2022. "Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice" International Journal of Molecular Sciences 23, no. 18: 10736.
https://doi.org/10.3390/ijms231810736
APA Style
Seidel, F., Kleemann, R., van Duyvenvoorde, W., van Trigt, N., Keijzer, N., van der Kooij, S., van Kooten, C., Verschuren, L., Menke, A., Kiliaan, A. J., Winter, J., Hughes, T. R., Morgan, B. P., Baas, F., Fluiter, K., & Morrison, M. C.
(2022). Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences, 23(18), 10736.
https://doi.org/10.3390/ijms231810736
